NOW ENROLLING

Phase III trial in
relapsed/refractory
acute myeloid
leukemia (AML)

Patients with
relapsed/refractory AML

Learn about this
Phase III AML trial

MIRROS
BioOncology Genentech

© 2019 Genentech USA, Inc. All rights reserved. BIO/040218/0052(2)